138 related articles for article (PubMed ID: 17637172)
1. Pharmacokinetics of letrozole in male and female rats: influence of complexation with hydroxybutenyl-beta cyclodextrin.
Wempe MF; Buchanan CM; Buchanan NL; Edgar KJ; Hanley GA; Ramsey MG; Skotty JS; Rice PJ
J Pharm Pharmacol; 2007 Jun; 59(6):795-802. PubMed ID: 17637172
[TBL] [Abstract][Full Text] [Related]
2. The effect of tamoxifen on the pharmacokinetics of letrozole in female rats.
Tao X; Brodie AM; Nnane IP
Biopharm Drug Dispos; 2006 Oct; 27(7):335-44. PubMed ID: 16912967
[TBL] [Abstract][Full Text] [Related]
3. Pharmacokinetics of raloxifene in male Wistar-Hannover rats: influence of complexation with hydroxybutenyl-beta-cyclodextrin.
Wempe MF; Wacher VJ; Ruble KM; Ramsey MG; Edgar KJ; Buchanan NL; Buchanan CM
Int J Pharm; 2008 Jan; 346(1-2):25-37. PubMed ID: 17644287
[TBL] [Abstract][Full Text] [Related]
4. Gender difference in letrozole pharmacokinetics in rats.
Liu XD; Xie L; Zhong Y; Li CX
Acta Pharmacol Sin; 2000 Aug; 21(8):680-4. PubMed ID: 11501174
[TBL] [Abstract][Full Text] [Related]
5. Biotransformation of letrozole in rat liver microsomes: effects of gender and tamoxifen.
Tao X; Piao H; Canney DJ; Borenstein MR; Nnane IP
J Pharm Biomed Anal; 2007 Feb; 43(3):1078-85. PubMed ID: 17045772
[TBL] [Abstract][Full Text] [Related]
6. Pharmacokinetics of saquinavir after intravenous and oral dosing of saquinavir: hydroxybutenyl-beta-cyclodextrin formulations.
Buchanan CM; Buchanan NL; Edgar KJ; Little JL; Ramsey MG; Ruble KM; Wacher VJ; Wempe MF
Biomacromolecules; 2008 Jan; 9(1):305-13. PubMed ID: 18072746
[TBL] [Abstract][Full Text] [Related]
7. Formulation and biopharmaceutical evaluation of a transdermal patch containing letrozole.
Li L; Fang L; Xu X; Liu Y; Sun Y; He Z
Biopharm Drug Dispos; 2010 Mar; 31(2-3):138-49. PubMed ID: 20140970
[TBL] [Abstract][Full Text] [Related]
8. Enhanced oral absorption of saquinavir with Methyl-Beta-Cyclodextrin-Preparation and in vitro and in vivo evaluation.
Pathak SM; Musmade P; Dengle S; Karthik A; Bhat K; Udupa N
Eur J Pharm Sci; 2010 Nov; 41(3-4):440-51. PubMed ID: 20656025
[TBL] [Abstract][Full Text] [Related]
9. Complexation of tanshinone IIA with 2-hydroxypropyl-beta-cyclodextrin: effect on aqueous solubility, dissolution rate, and intestinal absorption behavior in rats.
Wang L; Jiang X; Xu W; Li C
Int J Pharm; 2007 Aug; 341(1-2):58-67. PubMed ID: 17482783
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of the bioavailability of flurbiprofen and its beta-cyclodextrin inclusion complex in four different doses upon oral administration to rats.
Muraoka A; Tokumura T; Machida Y
Eur J Pharm Biopharm; 2004 Nov; 58(3):667-71. PubMed ID: 15451543
[TBL] [Abstract][Full Text] [Related]
11. Inclusion complexes of tadalafil with natural and chemically modified beta-cyclodextrins. I: preparation and in-vitro evaluation.
Badr-Eldin SM; Elkheshen SA; Ghorab MM
Eur J Pharm Biopharm; 2008 Nov; 70(3):819-27. PubMed ID: 18655829
[TBL] [Abstract][Full Text] [Related]
12. Effects of RM-beta-CD on sublingual bioavailability of Delta9-tetrahydrocannabinol in rabbits.
Mannila J; Järvinen T; Järvinen K; Tarvainen M; Jarho P
Eur J Pharm Sci; 2005 Sep; 26(1):71-7. PubMed ID: 15955678
[TBL] [Abstract][Full Text] [Related]
13. Complex of 9-nitro-camptothecin in hydroxypropyl-beta-cyclodextrin: in vitro and in vivo evaluation.
Jiang Y; Sha X; Zhang W; Fang X
Int J Pharm; 2010 Sep; 397(1-2):116-21. PubMed ID: 20637848
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of carboxymethyl-beta-cyclodextrin with acid function: improvement of chemical stability, oral bioavailability and bitter taste of famotidine.
Mady FM; Abou-Taleb AE; Khaled KA; Yamasaki K; Iohara D; Taguchi K; Anraku M; Hirayama F; Uekama K; Otagiri M
Int J Pharm; 2010 Sep; 397(1-2):1-8. PubMed ID: 20600734
[TBL] [Abstract][Full Text] [Related]
15. Pharmacokinetics of itraconazole after intravenous and oral dosing of itraconazole-cyclodextrin formulations.
Buchanan CM; Buchanan NL; Edgar KJ; Klein S; Little JL; Ramsey MG; Ruble KM; Wacher VJ; Wempe MF
J Pharm Sci; 2007 Nov; 96(11):3100-16. PubMed ID: 17712849
[TBL] [Abstract][Full Text] [Related]
16. Physicochemical characteristics and oral bioavailability of andrographolide complexed with hydroxypropyl-beta-cyclodextrin.
Ren K; Zhang Z; Li Y; Liu J; Zhao D; Zhao Y; Gong T
Pharmazie; 2009 Aug; 64(8):515-20. PubMed ID: 19746840
[TBL] [Abstract][Full Text] [Related]
17. Pharmacokinetics of tamoxifen after intravenous and oral dosing of tamoxifen-hydroxybutenyl-beta-cyclodextrin formulations.
Buchanan CM; Buchanan NL; Edgar KJ; Little JL; Malcolm MO; Ruble KM; Wacher VJ; Wempe MF
J Pharm Sci; 2007 Mar; 96(3):644-60. PubMed ID: 17083091
[TBL] [Abstract][Full Text] [Related]
18. Kinetic study of a 2-hydroxypropyl-beta-cyclodextrin-based formulation of all-trans-retinoic acid in Sprague-Dawley rats after oral or intravenous administration.
Lin HS; Chan SY; Low KS; Shoon ML; Ho PC
J Pharm Sci; 2000 Feb; 89(2):260-7. PubMed ID: 10688755
[TBL] [Abstract][Full Text] [Related]
19. The pharmacokinetics of letrozole in brain and brain tumor in rats with orthotopically implanted C6 glioma, assessed using intracerebral microdialysis.
Dave N; Gudelsky GA; Desai PB
Cancer Chemother Pharmacol; 2013 Aug; 72(2):349-57. PubMed ID: 23748921
[TBL] [Abstract][Full Text] [Related]
20. Pharmacokinetic study of a new synthetic MMP inhibitor (Ro 28-2653) after IV and oral administration of cyclodextrin solutions.
Piette M; Evrard B; Frankenne F; Chiap P; Bertholet P; Castagne D; Foidart JM; Delattre L; Piel G
Eur J Pharm Sci; 2006 Jun; 28(3):189-95. PubMed ID: 16520026
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]